Works matching IS 15268209 AND DT 2015 AND VI 15 AND IP 3


Results: 10
    1
    2
    3
    4
    5
    6
    7

    Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.

    Published in:
    Clinical Breast Cancer, 2015, v. 15, n. 3, p. 191, doi. 10.1016/j.clbc.2014.12.003
    By:
    • Satoru Tanaka;
    • Mitsuhiko Iwamoto;
    • Kosei Kimura;
    • Nobuki Matsunami;
    • Hirotaka Morishima;
    • Katsuhide Yoshidome;
    • Takashi Nomura;
    • Takashi Morimoto;
    • Daigo Yamamoto;
    • Yu Tsubota;
    • Toshihiro Kobayashi;
    • Kazuhisa Uchiyama
    Publication type:
    Article
    8
    9
    10